牛牛AI助理已提取核心訊息
Douglas M. Lankler, Executive Vice President of Pfizer Inc. (PFE), was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. Consequently, the number of shares Lankler holds after the transaction remains unknown.
Douglas M. Lankler, Executive Vice President of Pfizer Inc. (PFE), was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. Consequently, the number of shares Lankler holds after the transaction remains unknown.
據報道，輝瑞公司（PFE）執行副總裁道格拉斯·蘭克勒於2024年2月27日參與了一項涉及該公司股票的交易。公告中未披露交易的具體細節，包括交易的股票數量、股票的性質、交易價格和股票的總價值。因此，蘭克勒在交易後持有的股票數量仍然未知。
據報道，輝瑞公司（PFE）執行副總裁道格拉斯·蘭克勒於2024年2月27日參與了一項涉及該公司股票的交易。公告中未披露交易的具體細節，包括交易的股票數量、股票的性質、交易價格和股票的總價值。因此，蘭克勒在交易後持有的股票數量仍然未知。
有用
沒用